Geriatric Medicines Market Estimated over USD 1,157.34 Billion By 2026
The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research.Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.
Request a sample or make an Inquiry before buying this report by clicking the link below:
https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/
The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions. Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.
The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography.
On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.
North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.
Global Geriatric Medicines Market Key Players:
GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.
About the Company:
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.
Polaris Market Research
30 Wall Street
8th Floor
New York City, NY 10005
United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geriatric Medicines Market Estimated over USD 1,157.34 Billion By 2026 here
News-ID: 1156850 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR โฆ
๐ป๐๐ ๐๐๐๐๐๐ ๐ช๐๐๐๐๐๐ ๐ญ๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐
๐๐ ๐ผ๐บ๐ซ 2.42 ๐๐๐๐๐๐๐ ๐๐ 2023. ๐ณ๐๐๐๐๐๐ ๐๐๐๐๐๐๐
, ๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐๐๐๐
๐๐ ๐๐๐๐ ๐๐ ๐ผ๐บ๐ซ 4.66 ๐๐๐๐๐๐๐ ๐๐ 2032, ๐๐๐๐๐๐๐๐๐๐ ๐ ๐๐๐๐๐๐๐๐
๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐ (๐ช๐จ๐ฎ๐น) ๐๐ 7.70% ๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐
๐๐๐๐ 2024 ๐๐ 2032. ๐ป๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐ ๐
๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐ ๐
๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐
๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐
๐๐๐, ๐๐ ๐๐๐๐ ๐๐ ๐ ๐๐๐๐ ๐๐ ๐๐๐ ๐
๐๐๐๐๐
๐๐๐ ๐๐๐๐๐๐ ๐๐๐
โฆ
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2 โฆ
The global Connected Medical Devices Market was valued at USD 49.57 billion in 2022. Looking forward, the market is projected to grow to USD 190.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% over the forecast period from 2023 to 2032.
The rising aging population and the expansion of telehealth services are the primary factors propelling the market forward. Besides, the growing prevalence of chronic diseasesโฆ
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by โฆ
According to a new market research report published by Polaris Market Research, the global Surgical Blade Market is expected to grow at a CAGR of 5.0% from 2023 to 2032. Its examination of technological progressions and developments in the industry and their influence on market attendance is anticipated to drive market expansion.
The global market was valued at USD 140.59 million in 2022 to USD 228.57 million by 2032, disclosingโฆ
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion โฆ
๐
๐ซ๐ฎ๐๐ญ๐จ๐จ๐ฅ๐ข๐ ๐จ๐ฌ๐๐๐๐ก๐๐ซ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
Continuing research into the health benefits of FOS and inventive commodity advancement has the possibility of capitulating new FOS-dependent commodities with improved functionality, which is pushing the market growth. Our thorough analysis of the Fructooligosaccharides Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments.
๐๐ก๐ ๐
๐ซ๐ฎ๐๐ญ๐จ๐จ๐ฅ๐ข๐ ๐จ๐ฌ๐๐๐๐ก๐๐ซ๐ข๐๐๐ฌ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
โข Market Size: The global market for fructooligosaccharides was valuedโฆ
More Releases for Geriatric
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi โฆ
Governmentsโ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel theโฆ
Cataract Market Geriatric & Future Scenario 2025
Global Cataract Market: Snapshot
The incrementing demand in the global cataract market is a reflection of growing geriatric population, as people aged over 60 years frequently develop conditions wherein eyes have reduced elasticity and in turn affects the normal functioning. The market for cataract is also expected to gain from awareness programs such as VISION 2020, launched by the WHO and the International Agency for the Prevention of Blindness.
Request Sample Copyโฆ
Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic โฆ
Researchmoz added Most up-to-date research on "Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic Ailments among Geriatric Population Crea" to its huge collection of research reports.
Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffersโฆ
Geriatric Medicines Market Analysis & Trends 2023
The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015โ2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023.
Governmentsโ Push for Quality Geriatric Care Bodes Well for Market
The global geriatric medicines market is primarily driven the general rise in the elderly populationsโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G โฆ
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Complementary and alternative medicines include products such as dietary medicineโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl โฆ
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Browse to unlockโฆ